2016 WOUND CARE
PRODUCT SELECTION GUIDE
1
How to Use This Guide*
This guide is intended to be used as a wound management resource for all members of the
healthcare team involved in the assessment and management of wounds. This resource
includes images to help serve as a reference for you regarding wound severity and when used
in conjunction with holistic patient assessment helps you identify the corresponding Acelity
wound product(s) that may be appropriate for the management and treatment of individual
wounds.
Follow these three steps to use the guide:
1. Use the Table of Contents on page three (3) to find the appropriate page number of the
wound that you are assessing.
2. Find the appropriate treatment for the wound and your assessment.
3. M
ove down the chart to see the Acelity product(s) that may be appropriate for your
patients and go to the referenced page.
*Guide and references are to be used in conjunction with good clinical practice; utilize appropriate debridement and/or antibiotics where necessary. Untreated osteomyelitis is contraindicated for use
with V.A.C.® Negative Pressure Wound Therapy.
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for all KCI and Systagenix products and therapies. Prior to the use of any medical device, it is
important for the provider to consult the treating physician and read and understand all Instructions for Use, including Safety Information, Dressing Application Instructions, and Therapy Device
Instructions. Rx only.
2
Table of Contents
Wound Classification Systems
Diabetic Foot Ulcer Wagner Grading System. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 4
Pressure Ulcer Classification System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 5
Comprehensive Classification System for Chronic Venous Disorders (CEAP) . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 7
Surgical Site Infection Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Page 8
General Product Selection
Venous Leg Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Diabetic Foot Ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Pressure Ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Non-Healing Surgical Wounds. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Arterial Ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Acelity Products
Negative Pressure Wound Therapy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Disposable NPWT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Advanced Wound Dressings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Regenerative Tissue Matrix. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Open Abdomen Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Incision Management System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Epidermal Harvesting System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Wound Glossary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3
Wound Classification Systems
Diabetic Foot Ulcer Wagner Grading System
Grade 0
Intact Skin
Grade 1
Superficial ulcer
of skin or
subcutaneous
tissue
Grade 2
Ulcers extend
into tendon,
bone, or joint
capsule
Grade 3
Deep ulcer with
osteomyelitis
or abscess
Grade 4
Gangrene of
toes or forefoot
Grade 5
Midfoot
or hindfoot
gangrene
4
Pressure Ulcer Classification System
Pressure Ulcer Classification System*
Pressure Ulcer Stages/CAtegories
Category/Stage I: Non-blanchable erythema
Intact skin with non-blanchable redness of a localized area usually over a bony prominence. Darkly pigmented skin may not have visible blanching; its color may differ
from the surrounding area. The area may be painful, firm, soft, warmer or cooler as compared to adjacent tissue. Category I may be difficult to detect in individuals
with dark skin tones. May indicate “at risk” persons.
Category/Stage II: Partial thickness
Partial thickness loss of dermis presenting as a shallow open ulcer with a red pink wound bed, without slough. May also present as an intact or open/ruptured
serum-filled or sero-sanginous filled blister. Presents as a shiny or dry shallow ulcer without slough or bruising.** This category should not be used to describe skin
tears, tape burns, incontinence associated dermatitis, maceration or excoriation.
Category/Stage III: Full thickness skin loss
Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon or muscle are not exposed. Slough may be present but does not obscure the depth
of tissue loss. May include undermining and tunneling. The depth of a Category/Stage III pressure ulcer varies by anatomical location. The bridge of the nose, ear,
occiput and malleolus do not have (adipose) subcutaneous tissue and Category/Stage III ulcers can be shallow. In contrast, areas of significant adiposity can develop
extremely deep Category/Stage III pressure ulcers. Bone/tendon is not visible or directly palpable.
Category/Stage IV: Full thickness tissue loss
Full thickness tissue loss with exposed bone, tendon or muscle. Slough or eschar may be present. Often includes undermining and tunneling. The depth of a Category/Stage IV pressure ulcer varies by anatomical location. The bridge of the nose, ear, occiput and malleolus do not have (adipose) subcutaneous tissue and these
ulcers can be shallow. Category/Stage IV ulcers can extend into muscle and/or supporting structures (e.g., fascia, tendon or joint capsule) making osteomyelitis or
osteitis likely to occur. Exposed bone/muscle is visible or directly palpable.
Additional Categories/Stages for the USA
Unstageable/Unclassified: Full thickness skin or tissue loss – depth unknown
Full thickness tissue loss in which actual depth of the ulcer is completely obscured by slough (yellow, tan, gray, green or brown) and/or eschar (tan, brown or black)
in the wound bed. Until enough slough and/or eschar are removed to expose the base of the wound, the true depth cannot be determined; but it will be either a
Category/Stage III or IV. Stable (dry, adherent, intact without erythema or fluctuance) eschar on the heels serves as “the body’s natural (biological) cover” and should
not be removed.
Suspected Deep Tissue Injury – depth unknown
Purple or maroon localized area of discolored intact skin or blood-filled blister due to damage of underlying soft tissue from pressure and/or shear. The area may be
preceded by tissue that is painful, firm, mushy, boggy, warmer or cooler as compared to adjacent tissue. Deep tissue injury may be difficult to detect in individuals
with dark skin tones. Evolution may include a thin blister over a dark wound bed. The wound may further evolve and become covered by thin eschar. Evolution may
be rapid exposing additional layers of tissue even with optimal treatment.
*“National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel. Pressure Ulcer Prevention and Treatment: Clinical Practice Guideline.” Washington, DC: National Pressure Ulcer Advisory Panel, 2009.
**Bruising indicates deep tissue injury.
5
Pressure Ulcer Classification System
Stage I:
Stage II:
Stage III:
Skin is intact with non-blanchable
redness over a bony area. The area
may be painful, firmer, softer, or
different in temperature compared
to the surrounding area. Darker skin
tones may not show differences.
Shiny or dry shallow ulcer. There is
partial thickness loss of dermis in a
shallow open ulcer, without slough.
Full thickness tissue loss without
bone, tendon, or muscle exposure.
Subcutaneous fat may be visible.
The depth of the ulcer varies with
the location.
Stage IV:
Unstageable:
Suspected Deep Tissue Injury:
Full thickness tissue loss with
exposed bone, tendon, or muscle.
The depth of the ulcer varies by
anatomical location.
Full thickness tissue loss with slough
obscuring the ulcer depth and/or
eschar in the wound bed. Stage can’t be
determined until slough and eschar are
removed but is either Stage III or IV.
Discolored purple or maroon area or bloodfilled blister due to underlying soft tissue
damage from pressure and/or shear. Tissue
may be painful, firm, mushy, warmer, or
cooler compared to adjacent tissue.
“National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel. Pressure Ulcer Prevention and Treatment: Clinical Practice Guideline.” Washington, DC: National Pressure Ulcer Advisory Panel, 2009.
NPUAP copyright and used with permission
6
Comprehensive Classification System for Chronic Venous Disorders (CEAP)
Comprehensive Classification System for Chronic Venous Disorders (CEAP)
C1- telangiectasias or
reticular veins
C2- varicose veins
C3- edema
C4- lipodermatosclerosis
and eczema
ClassificationDescription
C0
No visible or palpable signs of venous disease
C1
Telangiectasias or reticular veins
C2
Varicose veins
C5- ulcer scar
Classification of Venous Ulcers Etiology*
EC – Congenital
ES – Secondary (usually due to prior DVT)
AS – Superficial veins
C4a
Milder skin changes due to venous disorders (pigmentation, eczema)
C4b
Severe skin changes due to venous disorders (dermatosclerosis, atrophie blanche)
Pathophysiology*
PR - Reflux
C6
Skin changes with active ulcers
EP – Primary
Anatomy*
C3Edema
C5C4 along with healed ulcers
C6- active ulcer
AP – Perforating veins AD – Deep veins
PO - Obstruction
*Fronek HS and Bergan JJ. The Fundamentals of Phlebology: Venous Disease for Clinicians, 2004: 151
7
Surgical Site Infection Definitions
Surgical Site Infection (SSI) Definitions
Surgical Site Infection Criteria
Criterion Surgical Site Infection (SSI)
Superficial
Must meet the following criteria:
Incisional
Infection occurs within 30 days after any NHSN operative procedure (where day 1 = the procedure date), including those coded as ‘OTH’*
SSI
AND
involves only skin and subcutaneous tissue of the incision
AND
patient has at least one of the following:
a. purulent drainage from the superficial incision.
b. organisms isolated from an aseptically-obtained culture from the superficial incision or subcutaneous tissue.
c. superficial incision that is deliberately opened by a surgeon, attending physician** or other designee and is culture positive or not cultured
AND
patient has at least one of the following signs or symptoms: pain or tenderness; localized swelling; erythema; or heat. A culture negative finding does not meet this criterion.
d. diagnosis of superficial incisional SSI by the surgeon or attending physician** or other designee.
Comments
*List of ICD-9-CM Codes. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nhsn/XLS/ICD-9-cmCODEScurrent.xlsx Published October 1, 2009. Updated May 11,2015. Accessed October 1, 2015.
** The term attending physician for the purposes of application of the NHSN SSI criteria may be interpreted to mean the surgeon(s), infectious disease, other physician on the case, emergency physician or physician’s
designee (nurse practitioner or physician’s assistant).
There are two specific types of superficial incisional SSIs:
1. Superficial Incisional Primary (SIP) – a superficial incisional SSI that is identified in the primary incision in a patient that has had an operation with one or more incisions (e.g., C-section incision or chest incision for CBGB)
2. Superficial Incisional Secondary (SIS) – a superficial incisional SSI that is identified in the secondary incision in a patient that has had an operation with more than one incision (e.g., donor site incision for CBGB)
Criterion Surgical Site Infection (SSI)
Deep
Must meet the following criteria:
Incisional Infection occurs within 30 or 90 days after the NHSN operative procedure SSI
(where day 1 = the procedure date) according to the list on page 9
AND
Involves deep soft tissures of the incision (e.g., fascial and muscle layers)
AND
Patient has at least one of the following:
a. purulent drainage from the deep incision.
b. a deep incision that spontaneously dehisces, or is deliberatelyopened or aspirated by a surgeon, attending physician* or other designee and is cultured positive or not cultured
AND
patient has at least one of the following signs or symptoms: fever (>38O C); localized pain tenderness. A culture negative finding does not meet the criterion.
c. an abscess or other evidence of infection involving the deep incision that is detected on gross anatomical or histopathologic exam, or imaging test.
*The term attending physician for the purposes of application of the NHSN SSI criteria may be interpreted to mean the surgeon(s), infectious disease, other physician on the case, emergency physician or physician’s designee (nurse practitioner or physician’s assistant).
Comments There are two specific types of deep incisional SSIs:
1. Deep Incisional Primary (DIP) – a deep incisional SSI that is identified in a primary incision in a
patient that has had an operation with one or more incisions (e.g., C-section incision or chest
incision for CBGB)
2. D
eep Incisional Secondary (DIS) – a deep incisional SSI that is identified in the secondary incision in
a patient that has had an operation with more than one incision (e.g., donor site incision for CBGB)
Criterion Surgical Site Infection (SSI)
Organ/
Must meet the following criteria:
Space SSI Infection occurs within 30 or 90 days after the NHSN operative procedure (where day 1 = the procedure date) according to the list on page 9
AND
Infection involves any part of the body deeper than the fascial/muscle layers, that is opened or manipulated during the operative procedure
AND
Patient has at least one of the following:
a. p
urulent drainage from a drain that is placed into the organ/space (e.g., closed suction drainage
system, open drain, T-tube drain, CT guided drainage)
b. o
rganisms isolated from an aseptically-obtained
culture of fluid or tissue in the organ/space
c. an abscess or other evidence of infection involving the organ/space that is detected on gross
anatomical or histopathologic exam, or imaging test
AND
Meets at least one criterion for a specific organ/
space infection site listed on page 10. These criteria are in the Surveillance Definitions for Specific Types of Infections chapter.
8
Surgical Site Infection Definitions
Surveillance Period for Deep Incisional or Organ/Space SSI Following Selected NHSN Operative Procedure Categories. Day 1 = the date of the procedure.
30-day Surveillance
Code Operative Procedure
Code AAA
Abdominal aortic aneurysm repair
LAM AMP Limb amputation
LTP APPY Appendix surgery
NECK AVSD Shunt for dialysis
NEPH BILI Bile duct, liver or pancreatic surgery
OVRY CEA Carotid endarterectomy
PRST CHOL Gallbladder surgery
REC COLO Colon surgery
SB CSEC Cesarean section
SPLE GAST Gastric surgery
THOR HTP Heart transplant
THYR HYST Abdominal hysterectomy
VHYS KTP Kidney transplant
XLAP OTH 90-day Surveillance
Operative Procedure
Laminectomy
Liver transplant
Neck surgery
Kidney surgery
Ovarian surgery
Prostate surgery
Rectal surgery
Small bowel surgery
Spleen surgery
Thoracic surgery
Thyroid and/or parathyroid surgery
Vaginal hysterectomy
Exploratory Laparotomy
Other NHSN operative procedures not included
in these categories
Code Operative Procedure
BRST Breast surgery
CARD Cardiac surgery
CBGB Coronary artery bypass graft with both chest and donor site incisions
CBGC Coronary artery bypass graft with chest incision only
CRANCraniotomy
FUSN Spinal fusion
FX
Open reduction of fracture
HERHerniorrhaphy
HPRO Hip prosthesis
KPRO Knee prosthesis
PACE Pacemaker surgery
PVBY Peripheral vascular bypass surgery
RFUSN Refusion of spine
VSHN Ventricular shunt
Specific Sites of an Organ/Space SSI
CodeSite
BONE Osteomyelitis
BRST Breast abscess or mastitis CARD Myocarditis or pericarditis DISC Disc space
EAR Ear, mastoid
EMET Endometritis
ENDO Endocarditis
EYE Eye, other than conjunctivitis
GIT GI tract
HEP Hepatitis
IAB Intraabdominal, not specified
IC Intracranial brain abscess or dura
JNT Joint or bursa
CodeSite
LUNG Other infections of the respiratory tract
MED Mediastinitis
MEN Meningitis or ventriculitis
ORAL Oral cavity (mouth, tongue, or gums)
OREP Other infections of the male or female reproductive tract
PJI Periprosthetic Joint Infection
SA Spinal abscess without meningitis
SINU Sinusitis
UR Upper respiratory tract
USI Urinary System Infection
VASC Arterial or venous infection
VCUF Vaginal cuff
(Criteria for these sites can be found in the NHSN Help system [must be logged in to NHSN] or the Surveillance Definitions for Specific Types of Infections chapter).
9
GENERAL PRODUCT SELECTION
10
General Product Selection
Quick Reference Guide – General Product Selection
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement, antibiotics, and compression therapy as appropriate.
Microbial
Contamination
(Bioburden)
Stalled or
Delayed Healing
Exudate
Management
Needs Granulation
or Dermal
Replacement
Needs
Epidermal Coverage
Needs Compression,
as Clinically Indicated
(0.5-above 1.2 ABPI Index)
V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO™ or V.A.C. VERAFLO CLEANSE™ Dressings – PAGES 27-28
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ and/or V.A.C. WHITEFOAM™ Dressings – PAGES 22-26
SNAP™ Therapy System1
– PAGE 30
PROMOGRAN PRISMA™
Matrix1,2 – PAGES 35-36
PROMOGRAN™ Matrix Wound
Dressing or PROMOGRAN
PRISMA™ Matrix1,2
– PAGES 35-36
PROMOGRAN™ Matrix Wound Dressing or PROMOGRAN
PRISMA™ Matrix1,2 – PAGES 35-36
SILVERCEL™ NON-ADHERENT or SILVERCEL™ Antimicrobial Alginate Dressing1,2 – PAGES 37-38
Minimizing dressing adherence to the wound
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing or ADAPTIC™ Non-Adhering Dressing1,2 – PAGE 32
Secondary Dressing
TIELLE™ Family1 – PAGES 39-41
DYNA-FLEX™ Multi-layer
Compression System (to help
reduce the effects of venous
insufficiency) – PAGE 33
Primary or Secondary Dressings
TIELLE™ Family1 – PAGES 39-41
NU-DERM™ Hydrocolloid
Wound Dressing2
– PAGE 34
PREVENA™ Incision
Management System
(for closed incisions only)
– PAGE 44
CELLUTOME™ Epidermal
Harvesting System2
– PAGE 45
GRAFTJACKET® Matrices2 – PAGE 42
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE™ Family)
11
Venous Leg Ulcers
Venous Leg Ulcers
Healed or
Skin at Risk
Partial Thickness
Full Thickness
12
Venous Leg Ulcers
Venous Leg Ulcers
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement, antibiotics, and compression therapy as appropriate.
Microbial
Contamination
(Bioburden)
Stalled or
Delayed Healing
Exudate
Management
Needs Granulation
or Dermal
Replacement
Needs
Epidermal Coverage
Needs Compression,
as Clinically Indicated
(0.5-above 1.2 ABPI Index)
V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO™ or V.A.C. VERAFLO CLEANSE™ Dressings – PAGES 27-28
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ and/or V.A.C. WHITEFOAM™ Dressings – PAGES 22-26
SNAP™ Therapy System1
– PAGE 30
PROMOGRAN PRISMA™
Matrix1,2 – PAGES 35-36
PROMOGRAN™ Matrix Wound
Dressing or PROMOGRAN
PRISMA™ Matrix1,2
– PAGES 35-36
PROMOGRAN™ Matrix Wound Dressing or
PROMOGRAN PRISMA™ Matrix1,2 – PAGES 35-36
DYNA-FLEX™ Multi-layer
Compression System
– PAGE 33
SILVERCEL™ NON-ADHERENT or SILVERCEL™ Antimicrobial Alginate Dressing1,2 – PAGES 37-38
Minimizing dressing adherence to the wound
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing or ADAPTIC™ Non-Adhering Dressing1,2* – PAGE 32
Secondary Dressing
TIELLE™ Family1 – PAGES 39-41
Primary or Secondary Dressings TIELLE™ Family1 – PAGES 39-41
NU-DERM™ Hydrocolloid Wound
Dressing2 – PAGE 34
CELLUTOME™ Epidermal
Harvesting System2
– PAGE 45
GRAFTJACKET® Matrices2 – PAGE 42
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE™ Family)
13
Diabetic Foot Ulcers
Diabetic Foot Ulcers
What is the grade of the Diabetic Foot Ulcer as per the Wagner Grading System?
Grade 0
Intact Skin
Grade 1
Superficial ulcer
of skin or
subcutaneous
tissue
Grade 2
Ulcers extend
into tendon,
bone, or capsule
Grade 3
Deep ulcer with
osteomyelitis
or abscess
Grade 4
Gangrene of
toes or forefoot
Grade 5
Midfoot
or hindfoot
gangrene
14
Diabetic Foot Ulcers
Diabetic Foot Ulcers
Grades represent the Wagner Grading System appropriate for each product.
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics.
Microbial
Contamination
(Bioburden)
Stalled or
Delayed Healing
Exudate
Management
Needs Granulation
or Dermal
Replacement
Needs
Epidermal Coverage
Needs Compression,
as Clinically Indicated
(0.5-above 1.2 ABPI Index)
V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO™ or V.A.C. VERAFLO CLEANSE™ Dressings – PAGES 27-28
Not Applicable
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ and/or V.A.C. WHITEFOAM™ Dressings – PAGES 22-26
SNAP™ Therapy System1
– PAGE 30
PROMOGRAN PRISMA™
Matrix1,2 – PAGES 35-36
PROMOGRAN™ Matrix Wound
Dressing or PROMOGRAN
PRISMA™ Matrix1,2
– PAGES 35-36
PROMOGRAN™ Matrix Wound Dressing or
PROMOGRAN PRISMA™ Matrix1,2 – PAGES 35-36
SILVERCEL™ NON-ADHERENT or SILVERCEL™ Antimicrobial Alginate Dressing1,2 – PAGES 37-38
Minimizing dressing adherence to the wound
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing or ADAPTIC™ Non-Adhering Dressing1,2 – PAGE 32
Secondary Dressing
TIELLE™ Family1 – PAGES 39-41
Primary or Secondary Dressings
TIELLE™ Family1 – PAGES 39-41
NU-DERM™ Hydrocolloid
Wound Dressing2
– PAGE 34
CELLUTOME™ Epidermal
Harvesting System2
– PAGE 45
GRAFTJACKET® Matrices2 – PAGE 42
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE™ Family)
15
Pressure Ulcers
Pressure Ulcers
What is the grade of the Pressure Ulcer on the NPUAP Classification System?
Stage I
Non-blanchable
erythema
Stage II
Partial thickness
Stage III
Full thickness
skin loss
Stage IV
Full thickness
tissue loss
Unstageable
Full thickness skin
or tissue loss –
depth unknown
Suspected Deep
Tissue Injury
Depth unknown
16
Pressure Ulcers
REPLACE
IMAGE
Pressure Ulcers
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics.
Microbial
Contamination
(Bioburden)
Stalled or
Delayed Healing
Exudate
Management
Needs Granulation
or Dermal
Replacement
Needs
Epidermal Coverage
Needs Compression,
as Clinically Indicated
(0.5-above 1.2 ABPI Index)
V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO™ or V.A.C. VERAFLO CLEANSE™ Dressings – PAGES 27-28
Not Applicable
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ and/or V.A.C. WHITEFOAM™ Dressings – PAGES 22-26
PROMOGRAN PRISMA™
Matrix1,2 – PAGES 35-36
PROMOGRAN™ Matrix Wound
Dressing or PROMOGRAN
PRISMA™ Matrix1,2
– PAGES 35-36
PROMOGRAN™ Matrix Wound Dressing or
PROMOGRAN PRISMA™ Matrix1,2 – PAGES 35-36
SILVERCEL™ NON-ADHERENT or SILVERCEL™ Antimicrobial Alginate Dressing1,2 – PAGES 37-38
Minimizing dressing adherence to the wound
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing or ADAPTIC™ Non-Adhering Dressing1,2 – PAGE 32
Secondary Dressing
TIELLE™ Family1 – PAGES 39-41
Primary or Secondary Dressings
TIELLE™ Family1 – PAGES 39-41
NU-DERM™ Hydrocolloid
Wound Dressing2
– PAGE 34
CELLUTOME™ Epidermal
Harvesting System2
– PAGE 45
GRAFTJACKET® Matrices2 – PAGE 42
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE™ Family)
17
Non-Healing Surgical Wounds
Non-Healing Surgical Wounds
Superficial
Incisional
Deep Incisional
Organ/Space
18
Non-Healing Surgical Wounds
Non-Healing Surgical Wounds
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics.
Microbial
Contamination
(Bioburden)
Stalled or
Delayed Healing
Exudate
Management
Needs Granulation
or Dermal
Replacement
Needs
Epidermal Coverage
Needs Compression,
as Clinically Indicated
(0.5-above 1.2 ABPI Index)
V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO™ or V.A.C. VERAFLO CLEANSE™ Dressings – PAGES 27-28
Not Applicable
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ and/or V.A.C. WHITEFOAM™ Dressings – PAGES 22-26
PROMOGRAN PRISMA™
Matrix1,2 – PAGES 35-36
PROMOGRAN™ Matrix Wound
Dressing or PROMOGRAN
PRISMA™ Matrix1,2
– PAGES 35-36
PROMOGRAN™ Matrix Wound Dressing or
PROMOGRAN PRISMA™ Matrix1,2 – PAGES 35-36
SILVERCEL™ NON-ADHERENT or SILVERCEL™ Antimicrobial Alginate Dressing1,2 – PAGES 37-38
Minimizing dressing adherence to the wound
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing or ADAPTIC™ Non-Adhering Dressing1,2 – PAGE 32
Secondary Dressing
TIELLE™ Family1 – PAGES 39-41
Primary or Secondary Dressings
TIELLE™ Family1 – PAGES 39-41
NU-DERM™ Hydrocolloid
Wound Dressing2
– PAGE 34
PREVENA™ Incision
Management System
(for closed incisions only)
– PAGE 44
CELLUTOME™ Epidermal
Harvesting System2
– PAGE 45
GRAFTJACKET® Matrices2 – PAGE 42
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE™ Family)
19
Arterial Ulcers
Arterial Ulcers
Dry, Stable Eschar
Partial thickness
Full-thickness
20
Arterial Ulcers
Arterial Ulcers
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics and/or thorough vascular assessment with appropriate intervention.
Microbial
Contamination
(Bioburden)
PROMOGRAN PRISMA™
Matrix1,2 – PAGES 35-36
Stalled or
Delayed Healing
Exudate
Management
PROMOGRAN™ Matrix Wound
Dressing or PROMOGRAN
PRISMA™ Matrix1,2
– PAGES 35-36
Needs Granulation
or Dermal
Replacement
Needs
Epidermal Coverage
Needs Compression,
as Clinically Indicated
(0.5-above 1.2 ABPI Index)
PROMOGRAN™ Matrix Wound Dressing or
PROMOGRAN PRISMA™ Matrix1,2 – PAGES 35-36
Not Applicable
SILVERCEL™ NON-ADHERENT or SILVERCEL™ Antimicrobial Alginate Dressing1,2 – PAGES 37-38
Minimizing dressing adherence to the wound
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing or ADAPTIC™ Non-Adhering Dressing1,2 – PAGE 32
Secondary Dressing
TIELLE™ Family1 – PAGES 39-41
Primary or Secondary Dressings
TIELLE™ Family1 – PAGES 39-41
CELLUTOME™ Epidermal
Harvesting System2
– PAGE 45
GRAFTJACKET® Matrices2 – PAGE 42
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE™ Family)
21
Negative Pressure Wound Therapy
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ Dressing
What is it?
V.A.C.® Therapy promotes wound healing through well-established mechanisms of action
Macrostrain:Microstrain:1-4
• Decreases wound margins
Promotes granulation tissue formation
• Removes exudate
and perfusion by means of:
• Reduces edema
• Cell proliferation
• Removes infectious material
• Fibroblast migration
SENSAT.R.A.C.™ Technology with EASYCLEAR™ Purge Technology
Only KCI V.A.C.® Therapy provides patented SENSAT.R.A.C.™ Technology, a real-time
pressure feedback system that adjusts pump output, compensating for wound distance,
wound position, exudate characteristics, and patient movement. EASYCLEAR™ Purge
Technology facilitates exudate removal and helps increase accuracy of blockage alarm.
Why use V.A.C.® Therapy with V.A.C.® GRANUFOAM™ Dressings in a wide
variety of wounds?
• V.A.C.® Therapy promotes granulation tissue formation while providing a closed, moist
wound healing environment.
• V.A.C.® GRANUFOAM™ Dressing can be easily trimmed to fit the contours of deep or
irregularly shaped wounds and are available in a variety of configurations for bridging
techniques and offloading when treating multiple wounds.
22
Negative Pressure Wound Therapy
V.A.C.® Therapy with V.A.C.® GRANUFOAM SILVER™ Dressing
What is it?
V.A.C.® GRANUFOAM SILVER™ Dressing is an advanced wound dressing to assist granulation
tissue formation and enhance exudate removal — with the effective bacterial barrier
properties of silver.
V.A.C.® Therapy promotes wound healing through well-established mechanisms of action
Macrostrain:Microstrain:1-4
• Decreases wound margins
Promotes granulation tissue formation
• Removes exudate
and perfusion by means of:
• Reduces edema
• Cell proliferation
• Removes infectious material
• Fibroblast migration
Why use V.A.C.® Therapy for chronic, critically colonized, or infected wounds*?
• V.A.C.® Therapy promotes granulation tissue formation while providing a closed, moist wound
healing environment.
• V.A.C.® GRANUFOAM SILVER™ Dressing:
– The only silver dressing that allows the V.A.C.® GRANUFOAM™ Dressing pores to come in
direct contact with the wound, eliminating the need for additional silver dressing layers
that may inhibit negative pressure and granulation.
– Micro-bonded metallic silver is uniformly distributed throughout the dressing, providing silver even after sizing.
– Easy-to-use: A single application of V.A.C.® GRANUFOAM SILVER™ Dressing eliminates the need for adjunct silver dressings.
– Effective protection: Based on in-vitro microbial testing, provides an effective barrier to
bacterial penetration. The protective silver ion reduces aerobic, gram-negative and gram-positive bacteria, and may help reduce infections in wounds.
* When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics.
23
Negative Pressure Wound Therapy
V.A.C.® Therapy with V.A.C.® SIMPLACE™ EX Dressing/SIMPLACE™ Dressing with 3M™ Tegaderm™ Drape
What is it?
• V.A.C.® SIMPLACE™ Dressings have been specifically designed to simplify the V.A.C.® Therapy
dressing placement process.
V.A.C.® Therapy promotes wound healing through well-established mechanisms of action
Macrostrain:Microstrain:1-4
• Decreases wound margins
Promotes granulation tissue formation
• Removes exudate
and perfusion by means of:
• Reduces edema
• Cell proliferation
• Removes infectious material
• Fibroblast migration
Why use V.A.C.® Therapy in difficult anatomical areas?
• Designed to simplify the V.A.C.® Therapy dressing placement process
• Spiral-cut foam is simple to size
• No scissors necessary
• V.A.C.® SIMPLACE™ EX Dressing: Precut V.A.C.® Strips provides easier application and fewer steps for bridging
• V.A.C.® SIMPLACE™ EX Dressing is supplied with 2 V.A.C.® GRANUFOAM™ Spiral Dressings, 2 strips of V.A.C.® Drape, 1 SENSAT.R.A.C.™ Pad with connector, and 1 disposable ruler
•V
.A.C.® SIMPLACE™ Small Dressing with 3M™ Tegaderm™ Drape is supplied with 2 V.A.C.®
GRANUFOAM™ Spiral Dressings, 2 sheets of 3M™ Tegaderm™ Drape, 1 SENSAT.R.A.C.™ Pad with connector, and 1 disposable ruler
24
Negative Pressure Wound Therapy
V.A.C.® Therapy with V.A.C.® GRANUFOAM™ Bridge/Bridge XG Dressing
What is it?
• V.A.C.® GRANUFOAM™ Bridge Dressing Family is ideal for use with wounds in pressure
sensitive areas that require bridging.
• V.A.C.® GRANUFOAM™ Bridge Dressing includes components designed to simplify dressing
application including:
– A wicking layer that helps intact skin stay dry
– Integrated bridge allows for SENSAT.R.A.C.™ Pad placement away from wound site
V.A.C.® Therapy promotes wound healing through well-established mechanisms of action
Macrostrain:Microstrain:1-4
• Decreases wound margins
Promotes granulation tissue formation
• Removes exudate
and perfusion by means of:
• Reduces edema
• Cell proliferation
• Removes infectious material
• Fibroblast migration
Why use V.A.C.® Therapy in areas of pressure (plantar sacrum, etc.) wounds?
• V.A.C.® Therapy promotes granulation tissue formation while providing a closed, moist wound
healing environment.
• The V.A.C.® GRANUFOAM™ Bridge Dressing has been specifically designed to place the
SENSAT.R.A.C.™ Pad away from the wound site. This makes it ideal for use in diabetic foot
wounds requiring off-loading therapy or VLUs requiring compression therapy. This dressing
helps improve mobility, allowing patients to resume activities of daily living, and facilitates
patient transition to a non-acute care setting with an off-loading boot and V.A.C.® Therapy.
• The V.A.C.® GRANUFOAM™ Bridge Dressing is supplied with 1 V.A.C.® GRANUFOAM™ Dressing (6 x 17 x 1.9cm), 1 (67cm) with integrated SENSAT.R.A.C.™ Pad, 1 sheet of perforated V.A.C.®
Drape with pre-cut hole, and 1 disposable ruler.
•V
.A.C.® GRANUFOAM™ Bridge XG Dressing is supplied with 2 V.A.C.® GRANUFOAM™ Spiral
Dressings, 1 V.A.C.® GRANUFOAM™ Bridge Dressing (67cm) with integrated SENSAT.R.A.C.™ Pad, 1
sheet of V.A.C.® Drape, 1 sheet of perforated V.A.C.® Drape with pre-cut hole, and 1 disposable ruler.
25
Negative Pressure Wound Therapy
V.A.C.® Therapy with V.A.C. WHITEFOAM™ Dressing
What is it?
• V.A.C. WHITEFOAM™ Dressings are a versatile, polyvinyl alcohol dressing used for tunnels and undermining, in situations where hypergranulation responses are likely and to bolster split thickness skin grafts
• V.A.C.® Therapy promotes wound healing through well-established mechanisms of action
Macrostrain:Microstrain:1-4
• Decreases wound margins
Promotes granulation tissue formation • Removes exudate
and perfusion by means of:
• Reduces edema
• Cell proliferation
• Removes infectious material
• Fibroblast migration
Why use V.A.C. WHITEFOAM™ Dressings in a wide variety of wounds?
• V.A.C.® Therapy promotes granulation tissue formation while providing a closed, moist wound healing environment.
• V.A.C. WHITEFOAM™ Dressings have:
– Higher tensile strength facilitating removal from tunnels and undermining
– Opening cell non-reticulated properties to help minimize in growth of granulation tissue
for a more comfortable dressing change
– Less adherent material than V.A.C.® GRANUFOAM™ Dressing for use as a bolster for skin grafts is pre-moistened with sterile water
26
Negative Pressure Wound Therapy
V.A.C. VERAFLO™ Instillation Therapy
What is it?
V.A.C. VERAFLO™ Instillation Therapy combines the benefits of V.A.C.® Therapy with automated
delivery, soak and removal of topical wound solution.
V.A.C. VERAFLO™ Instillation Therapy can help:
CLEANSE the wound with instillation of topical wound cleaners in a consistent, controlled manner
Treat the wound with instillation of appropriate topical antimicrobial and antiseptic solutions and the
removal of infectious material
Heal the wound and prepare for primary or secondary closure
Why use V.A.C. VERAFLO™ Instillation Therapy?
V.A.C. VERAFLO™ Instillation Therapy combines the benefits of V.A.C.® Therapy with
automated delivery, soak and removal of topical wound solution.
V.A.C. VERAFLO™ Instillation Therapy provides:
Volumetric Delivery
With a pump for automated delivery of topical wound solutions that can easily be
programmed to meet wound requirements
Fill Assist
Helps determine the correct solution volume to instill
Dressing Soak
Instills topical wound solution into the wound for easier dressing removal and increased
patient comfort at dressing change
A physician panel recommends to use V.A.C. VERAFLO™ Therapy5 when:
Patient has two or more clinically relevant co-morbidities OR
Wound is complex OR
Patient has an American Society of Anesthesiologists Physical Status Classification6 of ≥ 2
27
Negative Pressure Wound Therapy
V.A.C. VERAFLO™ Instillation Therapy
How to select V.A.C. VERAFLO™ Instillation Therapy setting considerations?5
Solution:
•If patient has received an aggressive operative debridement with little to no remaining infectious material,
slough or wound debris; consider normal saline
•If patient has received an extensive debridement and concerns of inadequate reduction in wound bioburden
remains or normal saline has not achieved desired results, consider compatible topical wound solutions (see
Solution Guide (DSL#14-0627.US (Rev. 10/14) LIT#29-A-212, Visit VeraFlo.com for document)
Soak Time:
•Consider 10- 20 minutes*
V.A.C.® Therapy Time:
•Consider 2-4 hours*
How to determine if V.A.C. VERAFLO™ Instillation Therapy can be considered successful?5
Sufficient robust granulation tissue is present in the wound bed such that primary closure can be achieved OR
Wound has reached a stage such that it can be covered with a flap or graft OR
Conventional NPWT can be initiated to further reduce the wound area at patient discharge
*Soak time is affected by solution selection. Consult solution manufacturer for recommended time. Both soak time and V.A.C.® Therapy time are affected by wound size
and anatomic location. Wounds with a greater leak potential should have shorter soak times and longer V.A.C.® Therapy times.
28
Negative Pressure Wound Therapy
V.A.C.® Therapy Units and Canisters
V.A.C.® GRANUFOAM™ and V.A.C.® SIMPLACE™ Dressings with SENSAT.R.A.C.™ Technology
Part Number
Description
ULTDEV01/USV.A.C.ULTA™ Therapy Unit, United States
340000ACTIV.A.C.™ Therapy Unit, United States
M8275063/10.SINFOV.A.C.™ 500ml Canister w/Gel, 10-pack
M8275063/5.SINFOV.A.C.™ 500ml Canister w/Gel, 5-pack
M8275071/10.SINFOV.A.C.™ 500ml Canister w/o Gel, 10-pack
M8275071/5.SINFOV.A.C.™ 500ml Canister w/o Gel, 5-pack
M8275093/5.SINFOV.A.C.™ 1000ml Canister w/Gel, 5-pack
M8275058/10ACTIV.A.C.™ Canister w/Gel-10, 300ml
M8275058/5ACTIV.A.C.™ Canister w/Gel-5, 300ml
Part Number
Description
M8275042/10
V.A.C.® GRANUFOAM™ Bridge Dressing, 10-pack
M8275042/5
V.A.C.® GRANUFOAM™ Bridge Dressing, 5-pack
M8275044/5
V.A.C.® GRANUFOAM™ Bridge XG Dressing, 5-pack
M8275051/10
V.A.C.® GRANUFOAM™ Small Dressing, 10-pack
M8275051/5
V.A.C.® GRANUFOAM™ Small Dressing, 5-pack
M8275052/10
V.A.C.® GRANUFOAM™ Medium Dressing, 10-pack
M8275052/5
V.A.C.® GRANUFOAM™ Medium Dressing, 5-pack
M8275053/10
V.A.C.® GRANUFOAM™ Large Dressing, 10-pack
M8275053/5
V.A.C.® GRANUFOAM™ Large Dressing, 5-pack
M8275065/5
V.A.C.® GRANUFOAM™ X-Large Dressing, 5-pack
M8275046/5V.A.C.® SIMPLACE™ EX Small Dressing, 5-pack
M8275045/5
V.A.C.® SIMPLACE™ EX Medium Dressing, 5-pack
M8275041/10
V.A.C.® SIMPLACE™ Small Dressing
M8275041/5
V.A.C.® SIMPLACE™ Small Dressing
M8275040/10
V.A.C.® SIMPLACE™ Medium Dressing
M8275040/5
V.A.C.® SIMPLACE™ Medium Dressing
V.A.C. WHITEFOAM™ Dressings with SENSAT.R.A.C.™ Technology
Part Number
M6275033/10
M6275034/10
M8275067/10
M8275067/5
M8275068/10
M8275068/5
Description
V.A.C. WHITEFOAM™ Small Dressing, Foam Only, 10-pack
V.A.C. WHITEFOAM™ Large Dressing, Foam Only, 10-pack
V.A.C. WHITEFOAM™ Large Dressing, 10-pack
V.A.C. WHITEFOAM™ Large Dressing, 5-pack
V.A.C. WHITEFOAM™ Small Dressing, 10-pack
V.A.C. WHITEFOAM™ Small Dressing, 5-pack
V.A.C.® GRANUFOAM SILVER™ Dressings
Part Number
M8275098/5
M8275098/10
M8275096/5
M8275096/10
M8275099/5
M8275099/10
Description
V.A.C.® GRANUFOAM SILVER™ Dressing, 5-pack, Small
V.A.C.® GRANUFOAM SILVER™ Dressing, 10-pack, Small
V.A.C.® GRANUFOAM SILVER™ Dressing, 5-pack, Medium
V.A.C.® GRANUFOAM SILVER™ Dressing, 10-pack, Medium
V.A.C.® GRANUFOAM SILVER™ Dressing, 5-pack, Large
V.A.C.® GRANUFOAM SILVER™ Dressing, 10-pack, Large
V.A.C. VERAFLO™ Therapy Dressings and Supplies
Part Number
ULTVFL05SM ULTVFL05MD ULTVCL05MD ULTLNK0500 ULTDUO0500 Description
V.A.C. VERAFLO™ Dressing, 5-pack, Small
V.A.C. VERAFLO™ Dressing, 5-pack, Medium
V.A.C. VERAFLO CLEANSE™ Dressing, 5-pack, Medium
V.A.C. VERALINK™ Cassette, 5-pack
V.A.C. VERAT.R.A.C. DUO™ Tube Set, 5-pack
References for pages 22-28
1. McNulty A, Spranger I, Courage J, et al. The consistent delivery of negative pressure to wounds using
reticulated, open cell foam and regulated pressure feedback. Wounds. 2010 May;22(5):114-120.
2. S axena V, Hwang C-W, Huang S, et al. Vacuum-assisted closure: microdeformations of wounds and
cell proliferation. Plastic and Reconstructive Surgery. 2004 Oct;114(5):1086-1096; discussion 1097-8.
3. M
cNulty AK, Schmidt M, Feeley T, Kieswetter K. et al. Effects of negative pressure wound therapy
on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix.
Wound Repair Regen. 2007 November 1;15(6):838-46.
4. McNulty AK, Schmidt M, Feeley T, et al. Effects of negative pressure wound therapy on cellular
energetics in fibroblasts grown in a provisional wound (fibrin) matrix. Wound Repair Regen. 2009
March 1;17(3):192-9.
5.Kim PJ, Attinger CE, Crist BD, et al. Negative pressure wound therapy with instillation: review of
evidence and recommendations Wounds. 2015;27(12):Suppl 1-20.
6.Fitz-Henry J. The ASA classification and peri-operative risk. Ann R Coll Surg Engl. 2011;93:185-87.
29
Disposable NPWT
SNAP™ Therapy System
What is it?
The SNAP™ Therapy System is a disposable, off-the-shelf NPWT solution that combines
the simplicity of advanced dressings with the benefits of negative pressure therapy.
Why use SNAP™ Therapy for DFU and VLU wounds?
• Ideal for small to medium DFUs and VLUs with low amounts of exudate
• Small, silent, lightweight system designed for ambulatory or elderly patients
• Medicare reimbursed in Wound Care Clinics (97607/8)
SNAP™ Therapy System
Part Number
Description
SNPA125
SNAP™ Therapy Cartridge, -125mmHg, 60ml
SKTF10X10
SNAP™ Advanced Dressing Kit (Foam), 10cm x 10cm
SKTF15X15
SNAP™ Advanced Dressing Kit (Foam), 15cm x 15cm
BKTF14X11
SNAP™ Bridge Dressing Kit (Foam), 14cm x 11cm
BKTF14X11S
SNAP™ Bridge Dressing Kit (Foam) with SecurRing™ Hydrocolloid, 14cm x 11cm
SRNG10
SNAP™ SecurRing™ Hydrocollloid, 2” diameter
STPAS
SNAP™ Therapy Strap, Small, 18”
STPAM
SNAP™ Therapy Strap, Medium, 21”
STPAL
SNAP™ Therapy Strap, Large, 24”
30
Advanced Wound Dressings
Acelity Products: Advanced Wound Dressings
Promote Granulation
Minimize Adherence
PROMOGRAN™ Matrix Wound Dressing and
PROMOGRAN PRISMA™ Matrix
To help promote a moist wound environment
conducive to granulation tissue formation,
epithelialization, and rapid wound healing.
ADAPTIC™ Non-Adhering Dressing and ADAPTIC TOUCH™ Non-Adhering Silicone Dressing
To help protect from adherence and minimize
trauma and pain on dressing removal.
Antimicrobial
Manage Exudate
SILVERCEL™ Antimicrobial Alginate and
SILVERCEL™ Non-Adherent Dressings
To help manage bacterial contamination and
infection, while also dealing with the secondary
symptoms of exudate and pain.
TIELLE™ Hydropolymer Adhesive Dressings
To help provide a comfortable and effective moist
wound environment for all types of wounds and/or
protect the wound from external contamination.
Compression
NU-DERM™ Hydrocolloid Wound Dressings
To help maintain a moist wound environment on non to
moderately exuding wounds. There are three variants in
the range, coming in a variety of shapes and sizes.
DYNA-FLEX™ Multi-Layer Compression System
To help reduce the effects of venous insufficiency
DYNA-FLEX™ Multi-Layer Compression System
provides proven sustained compression.
Please refer to the full Instructions for Use in the packaging insert.
31
Advanced Wound Dressings
ADAPTIC™ Non-Adhering Dressing and ADAPTIC TOUCH™ Non-Adhering Silicone
Dressing
What are they?
ADAPTIC™ Non-Adhering Dressing is a primary wound contact layer made of knitted cellulose acetate mesh,
impregnated with a petrolatum emulsion.
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing is a flexible, open-mesh primary wound contact layer comprised of
cellulose acetate coated with a soft tack silicone, designed to facilitate fluid transfer to secondary dressing and minimize
adherence and pain at dressing change. It may be used in conjunction with Negative Pressure Wound Therapy for the
protection of fragile wound structures.
ADAPTIC™ Non-Adhering Dressings
ADAPTIC TOUCH™ Non-Adhering Silicone Dressings
Item Code
2012
2013
2014
2015
2018
2019
Item Code
500501 500502
500503
500504
Size
3” x 3”
3” x 8”
3” x 16”
3” x 8”
3” x 60” Roll
5” x 9” Sheet
Each carton/box
HCPCS code
50 EA/CT - 12 CT/BX A6222
36 EA/CT - 6 CT/BX
A6223
36 EA/CT - 6 CT/BX
A6223
24 EA/CT - 6 CT/BX
A6223
10 rolls/BXA6266
12 EA/CT - 6 CT/BX
A6223
Size
2” x 3” 3” x 4 1/4”
5” x 6”
8” x 12 3/4”
Each carton/box
10 EA/CT - 5CT/BX
10 EA/CT - 5CT/BX
10 EA/CT - 5CT/BX
5 EA/bx
HCPCS code
A6206
A6206
A6207
A6208
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service#: 1-800-275-4524
Why use ADAPTIC TOUCH™ Dressings for wounds?
• Soft tack silicone assists dressing application, conformability and atraumatic removal1,2
• Advanced mesh design means minimized risk of exudate pooling and secondary dressing adherence
to the wound1,2
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service #: 1-800-275-4524
References:
1. Stephens S, Brosnan P, Mistry P, et al. Evaluation of a non-adhering silicone wound contact dressing with optimised design for the management of dry to heavily
exuding wounds (in-vitro/vivo). Poster, Wounds UK 2010.
2. Stephens S, Mishey P, Addison D, et al. Evaluation of the properties of a non-adhering silicone primary wound contact layer (in vitro). Poster, Wounds UK 2010.
32
Advanced Wound Dressings
DYNA-FLEX™ Multi-Layer Compression System
What is it?
DYNA-FLEX™ Multi-Layer Compression System provides proven sustained compression to reduce the effects
of venous insufficiency.
• First layer: Made of cool, breathable cotton and foam
• Second layer: Compression bandage uses an innovative, patented visual cue to aid proper application
• Third layer: Cohesive compression bandage helps prevents slippage and increases compliance
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service #: 1-800-275-4524
DYNA-FLEX™ Multi-Layer Compression System
Item code
Each carton/box
7025
8 units/CS
HCPCS code
A6223
A6421 – 1st Layer
A6430 – 2nd Layer
A6438 – 3rd Layer
Why use DYNA-FLEX™ Multi-Layer Compression System for wounds?
DYNA-FLEX™ Multi-Layer Compression System provides sustained compression for up to 7 days at both the ankle and below the knee, when used according to package insert directions. Each component has been carefully engineered to provide an effective solution ideal for use in all settings.
• Foam backing provides strength for added stretching and conformability
• Absorbs exudate
• Comfortable for the patient
• Helps protect the patient from pressure points
• The bandage is printed with a rectangular pattern that turns into a square when correct level of
stretch is achieved to assist in achieving reproducible pressures from one practitioner to another
• Reduces slippage
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert.
33
Advanced Wound Dressings
NU-DERM™ Hydrocolloid Wound Dressings
What is it?
NU-DERM™ Hydrocolloid Wound Dressings are designed to help maintain a moist wound
environment on non-exuding to moderately exuding wounds. There are three variants in the range,
coming in a variety of shapes and sizes.
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert.
NU-DERM™ Hydrocolloid Thin
NU-DERM™ Hydrocolloid Border
Item code Size
HCT101
4” x 4”
Item code
HCB102 HCB204 HCB106 Each tray/CAse
HCPCS code
10 EA/tray – 10 trays/CA A6234
NU-DERM™ Hydrocolloid Standard
HCF204 HCF208 4” x 4” 5 EA/tray – 10 trays/CA A6237
8” x 8” 5 EA/tray – 4 trays/CA A6236
Size
2” x 2” 4” x 4” 6” x 6” Each tray/CAse
HCPCS code
20 EA/tray – 5 trays/CA A6237
10 EA/tray – 16 trays/CA A6237
5 EA/tray – 4 trays/CA A6238
NU-DERM™ Hydrocolloid Border Sacrum
HCS100 6” x 7” 5 EA/tray – 4 trays/CA A6238
Why use NU-DERM™ Hydrocolloid Dressings for wounds?
• NU-DERM™ Hydrocolloid Dressings help maintain a moist wound healing environment
encouraging autolytic debridement, thus enabling granulation to proceed under optimum
conditions
• Designed to protect low risk wounds against outside bacterial contamination
• All NU-DERM™ Hydrocolloid Dressings are waterproof and can remain in place during
showering
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert.
34
Advanced Wound Dressings
PROMOGRAN™ Matrix Wound Dressing and PROMOGRAN PRISMA™ Matrix Family
What are they?
PROMOGRAN™ Matrix Wound Dressing is comprised of a sterile, freeze-dried composite of 45% oxidized
regenerated cellulose (ORC) and 55% collagen.
PROMOGRAN™ Matrix Wound Dressing
HCPCS code
A6021
A6022
PROMOGRAN™ Matrix
Wound Dressing
composed of
• 55% Collagen
• 45% ORC
PROMOGRAN PRISMA™
Matrix composed of
• 55% Collagen
• 45% ORC
• 1% Silver ORC
SKU
PG004
PG019
Size
4.34sq. in Hexagon
19.1sq. in Hexagon
Each/UOM
40
40
UOM packaged
10 EA/CT– 4 CT/BX
10 EA/CT– 4 CT/BX
PROMOGRAN PRISMA™ Matrix comprised of a sterile, freeze-dried composite of 44% oxidized
regenerated cellulose (ORC), 55% collagen and 1% silver-ORC. Silver-ORC contains 25% w/w ionically
bound silver, a well-known antimicrobial agent.
PROMOGRAN PRISMA™ Matrix
HCPCS code
A6021
A6022
SKU
MA028
MA123
Size
4.34sq. in Hexagon
19.1sq. in Hexagon
Each/UOM
40
40
UOM packaged
10 EA/CT– 4 CT/BX
10 EA/CT– 4 CT/BX
35
Advanced Wound Dressings
Why use PROMOGRAN™ Matrix Wound Dressing and PROMOGRAN PRISMA™ Matrix
• To help promote an optimal wound healing environment. This environment is conducive to
granulation tissue formation, epithelization and rapid wound healing.
• They are supported by a large body of clinical evidence, including 10 published RCTs and more than
100 supporting publications.1-3
• They have been demonstrated to achieve superior results in clinical practice1-5
• Significant reduction in wound area. A 12-week RCT involving VLU patients (n=73) found that
wounds in the PROMOGRAN™ Matrix Wound Dressing group experienced a significantly greater
reduction in wound areas compared to Control (54.4% vs. 36.5%, p<0.0001)3
• PROMOGRAN PRISMA™ Matrix contains ionic silver (silver - ORC), providing antimicrobial protection
against bacteria and infection.6
• In clinical practice PROMOGRAN PRISMA™ Matrix has been demonstrated to protect against
infection and promote healing in DFUs.5
• In the presence of exudate PROMOGRAN™ Matrix Wound Dressing and PROMOGRAN PRISMA™
Matrix, transform into a soft, conformable, biodegradable gel, which does not have to be removed
from the wound.
• The dressings can be cut with sterile scissors to fit the wound shape, or it can be pre-moistened to
form a gel and molded to fit the wound.
References:
1. Lazaro-Martinez J L, Garcia-Morales E, Beneit-Montesinos JV, et al. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of
neuropathic diabetic foot ulcers. F.R. Circ. Esp. 2007, 82(1), 27-31.
2. Veves A, Sheehan P, Pham H. A Randomized, Controlled Trial of Promogran (a Collagen Oxidized Regenerated Cellulose Dressing) vs. Standard Treatment in the Management of
Diabetic Foot Ulcers. Arch. Surg 2002, vol. 137:822-8274.
3. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J. Wound Care 2002; 11(9):335-415.
4. Lanzara S, Zambau P. A pilot randomized trial to determine the effects of a new active dressing on wound healing of venous leg ulcers. Presentation EWMA 2008.
5. Gottrup F, Cullen B, Karlsmerk T, et al. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Rep Reg 2013, 21:1-10.
6. Cullen B, Boyle C, Rennison T, et al. ORC/Collagen Matrix containing silver controls bacterial bioburden while retaining dermal cell viability. Poster, SAWC 2006.
7. Simmons R, Gibson M, Cullen B, et al. Effect of collagen ORC silver on bacterial proteases. Poster, CAWC 2013.
36
Advanced Wound Dressings
SILVERCEL™ Antimicrobial Alginate Dressing
What is it?
SILVERCEL™ Antimicrobial Alginate Dressing is a sterile, non-woven pad composed of high G (guluronic
acid) alginate, carboxymethylcellulose (CMC) and silver coated nylon fibers.
• The unique composition of the dressing manages exudate in moderate to heavily exuding wounds,
promoting a favorable environment for effective wound management
• SILVERCEL™ Antimicrobial Alginate Dressing provides a sustained release of silver ions within the
dressing for up to 7 days, allowing for an effective antimicrobial protection for the entire wear time,
depending on the level of exudate.1
• SILVERCEL™ Antimicrobial Alginate Dressing is effective against more than 150 wound pathogens1
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service #: 1-800-275-4524.
1. Teot L, Maggio G, Barrett S. The management of wounds using SILVERCEL™ Hydro-Alginate. Wounds UK Supplement. 2005.1(2)
SILVERCEL™ Antimicrobial Alginate Dressing
Item code
Size
800202
2” x 2” 8004044 1/4” x 4 1/4” 800408
4” x 8” 800112
1” x 12”
Each carton/box
10 EA/CT – 5 CT/BX
10 EA/CT – 5 CT/BX
10 EA/CT – 5 CT/BX
5 EA/CT – 5 CT/BX
HCPCS code
A6196
A6197
A6197
A6199
37
Advanced Wound Dressings
SILVERCEL™ NON-ADHERENT Antimicrobial Alginate Dressing
What is it?
SILVERCEL™ NON-ADHERENT Dressing is the next generation of Antimicrobial Dressing with the unique
feature of a Non-Adherent layer to maximize protection of the wound bed.
The unique feature of EASYLIFT™ Precision Film Technology designed for intact removal, helps minimize
the risk of adherence to the wound bed, fibers shedding and allows easy and pain-free removal.
SILVERCEL™ NON-ADHERENT Dressing
Item code
Size
Each carton/box
HCPCS code
900112
1” x 12”
5 EA/CT – 5 CT/BXA6199
900202
2” x 2”
10 EA/CT – 5 CT/BXA6196
9004044 1/4” x 4 1/4”10 EA/CT – 5 CT/BXA6197
900408
4” x 8”
5 EA/CT – 5 CT/BXA6197
Why use SILVERCEL™ Antimicrobial Alginate Dressing and SILVERCEL™ NON-ADHERENT Antimicrobial Alginate Dressing for wounds?
• The unique composition: a mixture of alginate, carboxymethylcellulose (CMC), and silver coated nylon
fibers manages exudate effectively in infected or heavily colonized wounds1
SILVERCEL™ NON-ADHERENT
Antimicrobial Alginate Dressing
• The unique EASYLIFT™ Precision Film layer allows intact and pain free removal minimizing pain and
trauma at dressing change for your patients2
• Help maintain a moist wound environment beneficial to wound healing
• Effective against a broad spectrum of wound pathogens, thus reducing wound malodor3
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert.
References:
SILVERCEL Antimicrobial
Alginate Dressing
™
1. Bogdanets L, Berezina S, Kuznetsov A, et al. New silver alginate dressing in the treatment of infected venous ulcers. EWMA, Glasgow, 2007. Page 247.
2. Clark R, Stephens S, DelBono M, Snyder R. From lab to leg: the importance of correlating in-vitro and in vivo test systems to clinical practice. SAWC 2010.
3. Clark R, Stephens S, DelBono M. The evaluation of absorbent silver containing dressings in-vitro. CAWC 2009.
38
Advanced Wound Dressings
TIELLE™ Family
What is it?
The TIELLE™ Family consists of a range of hydropolymer foam dressings with LIQUALOCK™ Advanced
Absorption Technology. The TIELLE™ Family is designed to manage different levels of exudates across a
range of wound types, helping minimize maceration. They come in a wide selection of shapes and sizes
with or without an adhesive border.
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service #: 1-800-275-4524
TIELLE™ Non-Adhesive Hydropolymer Dressing
Cut-able polyurethane foam dressing for low to highly exuding wounds
NEW
• In vitro it is able to retain fluid under pressure equivalent to that exerted by
compression bandaging (40mmHg) up to 7 days without leakage1
•Comfortable to wear, can be easily adapted, cut to shape and secured using the
most appropriate method for the patient, e.g. compression bandage
•TIELLE™ Non-Adhesive has improved fluid handling capacity by 30% compared
to TIELLE™ Xtra/Max/S1
TIELLE™ Silicone Border Hydropolymer Adhesive Dressing
Soft silicone for gentle removal on fragile and sensitive skin
NEW
Through the unique combination of LIQUALOCK™ Technology and soft silicone adhesive,
TIELLE™ Silicone Border:
•Helps maintain an optimal moist wound healing environment1,2
•Allows gentle removal2,3
References:
1.Stephens S. Macauley, N. Hill, C. DelBono, M, Parker, D. Poster, (In Vitro) Evaluation of the Performance of a Non-Adhesive Foam Dressing for the management of Wound Exudate. SAWC,
San Antonio April 2015.
2.Turton K, Parker D, Delbono M, Lane T. In vitro evaluations of the dual functionality of a new hydropolymer dressing with silicone for the management of exudate and atraumatic removal.
Wounds UK Harrogate 2015. Poster.
3.Turton K, Lane T, Parker, D, Delbono M, Di Palo S. In vitro evaluation of the atraumatic removal of a new hydropolymer dressing with silicone. Presented at Wound UK Harrogate 2015 Poster.
39
Advanced Wound Dressings
Why use the TIELLE™ Family Dressings for wounds?
•T
he TIELLE™ Family comes in a wide range of sizes, shapes, and absorbencies, allowing you to find a dressing that suits your patients’ needs
• The TIELLE™ Family contains LIQUALOCK™ Technology, which helps retain fluid to minimize leakage,
allowing moisture vapor to pass through the dressing, helping to provide an optimal moist wound
healing environment*
• The hydropolymer layer expands and conforms to the wound bed
• LIQUALOCK™ Technology ensures the fluid is locked away, minimizing the risk of leakage and maceration1
•M
anaging exudate better helps wounds heal faster and increases patient comfort
•M
inimize strike through
•T
he polyurethane backing is shower-proof, vapor permeable, and protects against external
environmental contamination**
•H
olds exudates even under pressure1
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert.
*TIELLE™ Dressing packing only has hydropolymer layer: TIELLE™ Lite includes an additional non-adherent wound contact layer.
**Adhesive border TIELLE™ Dressing variants only.
1. Mellor J and Boothman S. TIELLE™ hydropolymer dressings: wound responsive technology. Br J Community Nurse. 2003;8(11 Suppl): 14-7.
TIELLE™ Hydropolymer Dressings with LIQUALOCK™ Advanced Absorption Technology
Brand type
Item Code
Description
Size
Eaches/CArton/Box/CAse*
HCPCS
Cut-able
LIQUALOCK™ Advanced Absorption Technology
MTL300EN
TIELLE™ Lite 7cm x 9cm
7cm x 9cm / 2” x 3”
10ea per CT / 5CT per BX / 9BX per CS
A6212
-
LIQUALOCK Advanced Absorption Technology
MTL301EN
TIELLE Lite 11cm x 11cm
11cm x 11cm / 4” x 4”
10ea per CT / 5CT per BX / 4BX per CS
A6212
-
LIQUALOCK™ Advanced Absorption Technology
MTL308
TIELLE™ Lite 8cm x 15cm
8cm x 15cm / 3 1/8" x 5 7/8"
10ea per CT / 5CT per BX / 5BX per CS
A6213
-
LIQUALOCK™ Advanced Absorption Technology
MTL309
TIELLE™ Lite 8cm x 20cm
8cm x 20cm / 3 1/8" x 7 7/8"
10ea per CT / 5CT per BX / 5BX per CS
A6223
-
LIQUALOCK™ Advanced Absorption Technology
MTL310
TIELLE™ Lite 10cm x 30cm
10cm x 30cm / 4” x 11”
10ea per CT / 3CT per BX / 4BX per CS
A6213
-
LIQUALOCK™ Advanced Absorption Technology
MTL100EN
TIELLE™ Dressing 7cm x 9cm
7cm x 9cm / 2 ” x 3 ”
10ea per CT / 5CT per BX / 9BX per CS
A6212
-
LIQUALOCK Advanced Absorption Technology
MTL101EN
TIELLE Dressing 11cm x 11cm
11cm x 11cm / 4 ” x 4 ”
10ea per CT / 5CT per BX / 12BX per CS
A6212
-
LIQUALOCK™ Advanced Absorption Technology
MTL102
TIELLE™ Dressing 15cm x 20cm
15cm x 20cm / 5 7/8" x 7 7/8"
5ea per CT / 5CT per BX / 5BX per CS
A6213
-
LIQUALOCK Advanced Absorption Technology
MTL103
TIELLE Dressing 18cm x 18cm
18cm x 18cm / 7” x 7”
5ea per CT / 5CT per BX / 3BX per CS
A6213
-
TIELLE Lite Hydropolymer Adhesive Dressing
™
™
™
TIELLE Hydropolymer Adhesive Dressing
™
™
™
™
™
*NOTE: The sell-able unit of measure for the TIELLE Dressings with LIQUALOCK Advanced Absorption Technology is in Boxes ONLY.
™
™
40
Advanced Wound Dressings
TIELLE™ Family
TIELLE™ Hydropolymer Dressings with LIQUALOCK™ Advanced Absorption Technology (Cont.)
Brand type
Item Code
Description
Size
Eaches/CArton/Box/CAse*
HCPCS
Cut-able
LIQUALOCK™ Advanced Absorption Technology
MTP501
TIELLE™ Plus 11cm x 11cm
11cm x 11cm / 4” x 4”
10ea per CT / 5CT per BX / 4BX per CS
A6212
-
LIQUALOCK Advanced Absorption Technology
MTP502
TIELLE Plus 15cm x 20cm
15cm x 20cm / 5 7/8" x 7”
5ea per CT / 5CT per BX / 4BX per CS
A6213
-
LIQUALOCK™ Advanced Absorption Technology
MTP505
TIELLE™ Plus 15cm x 15cm
15cm x 15cm / 5 7/8" x 5 7/8"
10ea per CT / 5CT per BX / 2BX per CS
A6213
-
TIELLE Plus Hydropolymer Adhesive Dressing
™
™
™
TIELLE™ Max Non-Adhesive Hydropolymer Dressing
LIQUALOCK™ Advanced Absorption Technology
MTP701
TIELLE™ Max 11cm x 11cm
11cm x 11cm / 4” x 4”
10ea per CT / 5CT per BX / 8BX per CS
A6210
&
LIQUALOCK™ Advanced Absorption Technology
MTP702
TIELLE™ Max 15cm x 20cm
15cm x 20cm / 5 7/8" x 7 7/8"
5ea per CT / 5CT per BX / 5BX per CS
A6210
&
LIQUALOCK Advanced Absorption Technology
MTP705
TIELLE Max 15cm x 15cm
15cm x 15cm / 5 7/8" x 5 7/8"
10ea per CT / 5CT per BX / 4BX per CS
A6210
&
™
™
TIELLE Non-Adhesive Hydropolymer Dressing - NEW
™
LIQUALOCK™ Advanced Absorption Technology
TLN0505EN
TIELLE™ Non-Adhesive 5cm x 5cm
5cm x 5cm / 2" x 2"
10ea per CT / 5CT per BX / 16BX per CS
A6209
&
LIQUALOCK Advanced Absorption Technology
TLN1010EN
TIELLE Non-Adhesive 10cm x 10cm
10cm x 10cm / 4" x 4"
10ea per CT / 5CT per BX / 12BX per CS
A6209
&
LIQUALOCK Advanced Absorption Technology
TLN1515EN
TIELLE Non-Adhesive 15cm x 15cm
15cm x 15cm / 6" x 6"
10ea per CT / 5CT per BX / 4BX per CS
A6210
&
LIQUALOCK™ Advanced Absorption Technology
TLN1717EN
TIELLE™ Non-Adhesive 17.5cm x 17.5cm
17.5cm x 17.5cm / 7" x 7"
5ea per CT / 5CT per BX / 8BX per CS
A6211
&
LIQUALOCK Advanced Absorption Technology
TLN2122EN
TIELLE Non-Adhesive 21cm x 22cm
21cm x 22cm / 8" x 8 5/8"
5ea per CT / 5CT per BX / 5BX per CS
A6211
&
LIQUALOCK™ Advanced Absorption Technology
TLSB0709EN
TIELLE™ Silicone Border 7cm x 9cm
7cm x 9cm / 2" x 3”
10ea per CT / 5CT per BX / 4BX per CS
A6212
-
LIQUALOCK Advanced Absorption Technology
TLSB1010EN
TIELLE™ Silicone Border 10cm x 10cm
10cm x 10cm / 4" x 4"
10ea per CT / 5CT per BX / 4BX per CS
A6212
-
LIQUALOCK™ Advanced Absorption Technology
TLSB1212EN
TIELLE™ Silicone Border 12.5cm x 12.5cm
12.5cm x 12.5cm / 5" x 5"
10ea per CT / 5CT per BX / 4BX per CS
A6213
-
LIQUALOCK Advanced Absorption Technology
TLSB1717EN
TIELLE Silicone Border 17.5cm x 17.5cm
17.5cm x 17.5cm / 7" x 7"
5ea per CT / 5CT per BX / 4BX per CS
A6214
-
LIQUALOCK™ Advanced Absorption Technology
TLSB2122EN
TIELLE™ Silicone Border 21cm x 22cm
21cm x 22cm / 8" x 8 5/8"
5ea per CT / 5CT per BX / 3BX per CS
A6214
-
MT2450
TIELLE™ Packing 9.5cm x 9.5cm
9.5cm x 9.5cm / 3” x 3”
10ea per CT / 5CT per BX / 12BX per CS
A6215
&
MTL104
TIELLE™ Sacrum 17.5cm x 17.5cm
17.5cm x 17.5cm / 7” x 7”
5ea per CT / 5CT per BX / 3BX per CS
A6213
-
MTP506
TIELLE™ Plus Sacrum 15cm x 15cm
15cm x 15cm / 5 7/8"” x 5 7/8"
10ea per CT / 5CT per BX / 2BX per CS
A6254
-
MTP508
TIELLE™ Plus Heel 20cm x 26.5cm
20cm x 26.5cm / 7 7/8” x 10”
5ea per CT / 5CT per BX / 4BX per CS
A6213
-
™
™
™
™
™
™
TIELLE™ Silicone Border - NEW
™
™
™
TIELLE Packing Hydropolymer Dressing
™
LIQUALOCK™ Advanced Absorption Technology
TIELLE™ Sacrum
LIQUALOCK™ Advanced Absorption Technology
TIELLE™ Plus Sacrum
LIQUALOCK™ Advanced Absorption Technology
TIELLE Plus Heel
™
LIQUALOCK™ Advanced Absorption Technology
*NOTE: The sell-able unit of measure for the TIELLE Dressings with LIQUALOCK™ Advanced Absorption Technology is in Boxes ONLY.
™
41
Regenerative Tissue Matrix
GRAFTJACKET® Regenerative Tissue Matrix (RTM) and GRAFTJACKET® Xpress Flowable Soft Tissue Scaffold (FSTS)
What is it?
GRAFTJACKET® Regenerative Tissue Matrix for wounds provides a scaffold for the body’s repair or
replacement of damaged or inadequate integumental tissue, such as diabetic foot ulcers, venous leg
ulcers, pressure ulcers, or for other homologous uses of human integument.
• GRAFTJACKET® RTM is a thin, fenestrated acellular human dermal matrix designed for single
application
• GRAFTJACKET® Xpress FSTS is a micronized form of GRAFTJACKET® RTM (processed acellular
human dermis)
• GRAFTJACKET® Xpress FSTS is a flowable, acellular soft tissue treatment for tunneling and
irregularly contoured wounds
GRAFTJACKET® Regenerative Tissue Matrix
Part Number
GJ44
GJ48
GJX
Description
GRAFTJACKET® Regenerative Tissue Matrix, 4 x 4cm
GRAFTJACKET® Regenerative Tissue Matrix, 4 x 8cm
GRAFTJACKET® Xpress Flowable Soft Tissue Scaffold, 2cc
Why use for wounds needing dermal replacement?
• GRAFTJACKET® RTM:
– Requires only one application, in most cases, and can be placed in the operating room or
outpatient setting
– Provided in a thin sheet for conformability to the wound, maintaining surface area contact
when sutured or stapled in place
– Fenestrated to allow for wound fluid to escape
• GRAFTJACKET® Xpress FSTS:
– Conforms to the shape of the wound and fills deep tunneling and irregularly contoured wounds
– Replaces damaged or missing dermal tissue with ‘like’ tissue by supporting cellular repopulation
and revascularization by host tissue
42
Open Abdomen Management
ABTHERA™ Open Abdomen Negative Pressure Therapy
What is it?
ABTHERA™ Therapy is a temporary abdominal closure (TAC) system that helps surgeons take control early
when managing a challenging open abdomen, helping to achieve primary fascial closure.
ABTHERA™ Open Abdomen Negative Pressure Therapy
Part Number
Description
M8275026
ABTHERA™ SENSAT.R.A.C.™ OA Dressing, 5-pack. Compatible with V.A.C.ULTA™ and INFOV.A.C.™ Therapy Units
370605
ABTHERA™ OA Dressing (with interface pad), 5-pack. Compatible with ABTHERA™ Therapy Unit
370620
ABTHERA™ Canister, 20-pack. Compatible with ABTHERA™ Therapy Unit
370642
ABTHERA™ Tubing Set, 5-pack. Compatible with ABTHERA™ Therapy Unit
370500
ABTHERA™ Therapy Unit
Why use for open abdomen management?
ABTHERA™ Open Abdomen Negative Pressure Therapy:
- Actively removes fluid and helps reduce edema
- Provides medial tension which helps minimize fascial retraction and loss of domain1
- Provides separation between the abdominal wall and viscera, protecting abdominal contents
- Allows rapid access for re-entry and does not require sutures for placement
References:
1.Miller Pr, et al. Prospective evaluation of vacuum-assisted fascial closure after open abdomen: planned ventral hernia rate is substantially reduced. Ann Surg. 2004 May; 239(5):608-614.
43
Incision Management System
PREVENA™ Incision Management System
What is it?
The PREVENA™ Incision Management System is intended to manage the environment of surgical
incisions that continue to drain following sutured or stapled closure by maintaining a closed
environment and removing exudate via the application of negative pressure wound therapy.
PREVENA™ Incision Management System
AVAILABLE
JUNE, 2016
Part Number
Description
PRE1001USPREVENA™ PEEL & PLACE™ Kit, 20cm
PRE1055USPREVENA™ PEEL & PLACE™ Dressing - 20cm, 5-pack
PRE1101USPREVENA™ PEEL & PLACE™ Kit, 13cm
PRE1155USPREVENA™ PEEL & PLACE™ Dressing - 13cm, 5-pack
PRE1095PREVENA™ 45ml Canister, 5-pack
PRE2001USPREVENA™ CUSTOMIZABLE™ Kit
PRE2055USPREVENA™ CUSTOMIZABLE™ Dressing, 5-pack
PRE4001US
PREVENA PLUS™ System Kit
PRE4055US
PREVENA PLUS™ CUSTOMIZABLE™ Dressing, 5-pack
PRE4095
PREVENA PLUS™ Canister Kit, case of 5
PRE9090PREVENA™ V.A.C.® Connector, case of 10
Why use for incision management?
PREVENA™ Incision Management System:
– Holds incision edges together
– Protects incision site from external infectious sources
– Removes fluids and infectious materials from the surgical site
– Lightweight and portable
– Available in two PREVENA™ PEEL & PLACE™ Dressing options
• PEEL & PLACE™ Dressing - 13cm (for use on linear incisions up to 13cm)
• PEEL & PLACE™ Dressing - 20cm (for use on linear incisions up to 20cm)
–PREVENA™ CUSTOMIZABLE™ Dressing (for use on linear or non-linear incisions up to 90cm)
–PREVENA PLUS™ CUSTOMIZABLE™ System (for use on linear and non-linear incisions up to 90cm; with SENSAT.R.A.C.™ Technology and 150ml canister)
44
Epidermal Harvesting System
CELLUTOME™ Epidermal Harvesting System
What is it?
The CELLUTOME™ Epidermal Harvesting System is an innovative device that allows automated
creation and harvesting of patients’ own epidermal grafts that can easily be applied to a recipient
site for the first time in a wound care center.
CELLUTOME™ Epidermal Harvesting System
Part Number
Description
CT-KIT/USCELLUTOME™ Control Unit and CELLUTOME™ Vacuum Head
CT-CUSlCELLUTOME™ Control Unit Stand
CT-TFLM3M™ Tegaderm™ Film, box of 100
CT-H25CELLUTOME™ Harvester 2.5cm 5-pack
CT-H50CELLUTOME™ Harvester 5 x 5cm 5-pack
CT-5XT.5CELLUTOME™ Extension Strap 5-pack
500501
ADAPTIC TOUCH™ Non-Adhering Silicone Dressing 2” x 3”, box of 50
Why use the CELLUTOME™ Epidermal Harvesting System for wounds?
• Automated, precise and reproducible process
• Fast harvesting epidermal graft procedure, takes on average 45 minutes
• Can be performed by any suitably trained physician on your team
• No Local Coverage Determination (LCD) limitations on epidermal grafting
• Easily integrated into existing practice
45
Wound Glossary
Abrasion: S uperficial wound caused by the scraping away of the skin by mechanical means.
Abscess: Buildup of infected fluid/pus formed in tissue as a result of infection.
Alginate: A natural absorptive (hydrophilic) wound dressing manufactured from brown seaweed that gels upon contact with wound
exudate.
Bacterial contamination: Bacteria are present in the wound.
Blister: Collection of fluid below or within the epidermis caused by friction, burning, or other damage.
Cellulitis: Inflammation, redness, edema, and tenderness of the tissues — indicative of infection.
Colonization: Bacteria are dividing and have invaded the wound surface.
Debridement: Removal of dead, damaged, or infected tissue from a wound to improve the healing potential of the remaining healthy
tissue.
Dehiscence: A surgical complication in which a wound ruptures along surgical suture.
Erythema: Superficial reddening of the skin, usually in patches, as a result of injury or irritation causing dilatation of the blood
capillaries.
Eschar: Thick, dry, dark or black falling away of dead skin, typically caused by a burn.
Exudate: Wound fluid or drainage, often increased in inflammation.
Full-thickness wound: Tissue destruction extending through the dermis and may involve subcutaneous tissue and structures such as
muscle, bone or supporting structures (e.g., tendons or ligaments).
Gangrene: Localized death and decomposition of body tissue, resulting from either obstructed circulation or bacterial infection.
Granulating: Healthy red tissue which is deposited during the repair process, and presents as pinkish/red colored moist tissue and
has newly formed collagen, elastin, and capillary networks.
Hydrocolloid dressing: A category of wound dressings engineered with materials, such as gelatin, pectin, and carboxymethylcellulose
that provide a moist healing environment and adhere to the skin around the wound.
Hydrogel: Wound treatment using water- or glycerin-based gels, impregnated gauzes or sheet dressings. Hydrogels maintain a moist
healing environment and absorb a minimal amount of wound exudate.
Infected wound: High bacteria counts (often measured as >105) with tissue damage to surrounding tissue.
Instillation therapy: Delivery to and removal of topical wound solutions to the wound bed.
46
Wound Glossary
Necrotic: Dead tissue that usually results from an inadequate local blood supply. Necrotic tissue is further classified as slough or
eschar and color ranges from red to brown, black, or purple.
Osteomyelitis: An infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby
tissue. Osteomyelitis can also begin in the bone itself if an injury exposes the bone to germs.
Partial-thickness: Wounds that extend through the epidermis and may go into, but not through the dermis.
Primary dressing: The wound care product that is placed directly on top of the wound itself.
Secondary dressing: Holds the primary dressing in place.
Skin graft: Removal of partial or full-thickness segment of epidermis and dermis from its blood supply and transplanting it to another
site to speed healing and reduce the risk of infection.
Slough: Yellow fibrinous tissue that accumulates in a wound thought to be associated with bacterial activity. Slough consists of fibrin,
pus and proteinaceous material.
Tunneling: An opening from the wound base that may extend into the subcutaneous tissue or to muscle. Tunneling may occur from
infection, in pressure ulcers from shear or pressure forces or may occur from the overfilling of a wound with excess dressing material
which exerts pressure on surrounding tissues.
Undermining: Overhanging skin edges at the margin of the wound.
47
For more information, call 800-275-4524 or visit acelity.com
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for all KCI and Systagenix products and therapies. Prior to the use of any
medical device, it is important for the provider to consult the treating physician and read and understand all Instructions for Use, including Safety Information, Dressing
Application Instructions, and Therapy Device Instructions. Rx only.
©2016 KCI Licensing, Inc. and Systagenix Wound Management, Limited. All rights reserved. 3M and Tegaderm are trademarks of 3M Company. All other trademarks
designated within, unless otherwise noted, are proprietary to KCI Licensing, Inc. and Systagenix Wound Management, Limited, their respective affiliates and/or licensors.
DSL#16-0228.US.D (Rev. 4/16)